You can buy retatrutide in Dubai today, ship it cold-chain to Abu Dhabi tomorrow, and start a 48-week protocol by the weekend. None of that matters if you cannot answer one question at week 12: how much of what I lost was fat? Retatrutide, the triple-agonist peptide that drove the headline-grabbing 24% body-weight reductions in Jastreboff's 2023 New England Journal of Medicine paper, is a fundamentally different research molecule from semaglutide or tirzepatide. The glucagon arm pushes hepatic fat oxidation and resting energy expenditure. That changes where the body pulls from — and DEXA scan tracking is the only affordable, non-invasive way to actually see it.
This is the playbook UAE-based researchers and self-funded biohackers are using right now: where to scan in Dubai Marina, JBR, Business Bay, DIFC and Abu Dhabi, what each scan costs in AED, the four metrics that beat the bathroom scale, and how to lock in research-grade retatrutide UAE supply with REVIVE LAB UAE's 24h delivery so your protocol does not stall between scans.
The Jastreboff 2023 NEJM phase-2 trial of retatrutide in obesity is the single most-cited document in this category for good reason. At 48 weeks, the 12 mg arm hit a placebo-adjusted weight reduction of approximately 22.1% — numbers that no prior GLP-1 monotherapy had touched. But buried in the supplementary appendix is the more interesting signal: the composition of that loss. Participants on retatrutide preferentially shed visceral and subcutaneous fat mass, with a fat-to-lean loss ratio that compared favorably to semaglutide's published profile.
Mechanistically, this is what you would predict from a triple agonist. GLP-1 suppresses appetite and slows gastric emptying. GIP modulates adipocyte buffering and insulin sensitivity. The glucagon receptor — the third arm, the one tirzepatide does not touch — increases resting energy expenditure and hepatic lipolysis. The net effect on body composition is qualitatively different from a pure GLP-1, and that difference only shows up on a DEXA scan. The scale will tell you that you lost 11 kg in 12 weeks. The DEXA will tell you whether 9 kg of that was fat (excellent) or 6 kg of that was lean (a protocol failure).
For UAE researchers documenting a self-administered retatrutide protocol, this is non-negotiable data. The Emirates Hills crowd running 2 mg titrations alongside resistance training need to know the ratio. The Business Bay finance professional on a 12-week recomposition cycle needs to know visceral adipose tissue (VAT) is trending down independently of total weight. DEXA is how you prove it.
Retatrutide research protocols generally mirror the Jastreboff 2023 dosing structure: a slow titration starting at 2 mg weekly, escalating every four weeks until reaching a maintenance dose between 4 mg and 12 mg. REVIVE LAB UAE stocks 5 mg and 10 mg vials specifically because those two strengths cover every realistic titration step with minimal reconstitution math. The 10 mg vial reconstituted with 2 mL of BAC water gives clean 1 mg per 0.2 mL increments — perfect for stepwise escalation.
The DEXA cadence that matches this is straightforward: baseline at week 0, follow-ups at week 12, 24, 36 and 48. Five scans across one full protocol. That gives you four data deltas — one per quarter — which is the minimum resolution to detect whether the titration is working as predicted or whether you need to adjust training volume, protein intake, or the dose itself.
| Protocol Week | Typical Dose (research only) | DEXA Action | What to Look For |
|---|---|---|---|
| Week 0 (baseline) | None — start of protocol | Baseline scan | Anchor numbers: total fat, VAT, lean mass, android/gynoid ratio |
| Weeks 1-4 | 2 mg / week | No scan | Tolerance, GI side effects, appetite drop |
| Weeks 5-8 | 4 mg / week | No scan | Scale trend down 1-2% body weight |
| Week 12 | 4-6 mg / week | Q1 scan | 5-8% fat mass reduction, lean mass within 95% of baseline |
| Weeks 13-24 | 6-8 mg / week | — | Continued appetite suppression, energy stable |
| Week 24 | 8 mg / week | Q2 scan | VAT down 12-18%, android/gynoid ratio improving |
| Weeks 25-36 | 8-12 mg / week | — | Plateau risk — assess training and intake |
| Week 36 | 8-12 mg / week | Q3 scan | Total fat down 15-20% cumulative |
| Week 48 | Maintenance or taper | Q4 scan | Final ratio — fat loss should be 80%+ of total weight loss |
This is research framing only. The reason this cadence matters in the UAE specifically is supply continuity. A 48-week protocol means you need uninterrupted access to research-grade retatrutide for nearly a full year. If your supplier runs out at week 28, your data is contaminated. REVIVE LAB UAE keeps 5 mg and 10 mg vials in continuous stock with cold-chain courier delivery to every emirate — the operational reason most UAE researchers consolidate around a single trusted peptides Dubai source rather than rotating vendors mid-protocol.
Three things separate a useful DEXA series from a wasted one: same machine, same operator class, same time of day, same hydration state. If you scan at a Dubai Marina sports clinic at baseline and then a different brand of scanner in Abu Dhabi at week 24, the inter-machine variability can eat your quarterly delta. Pick one clinic. Stick with it. Book the same morning slot in a fasted state for every scan.
Typical AED pricing for private body-composition DEXA in Dubai falls in a fairly tight band:
| Clinic Tier | Typical Price (AED) | Includes |
|---|---|---|
| Standard radiology center | 350 - 500 | Whole-body composition, basic report |
| Sports-medicine clinic (DIFC, JBR, Dubai Marina) | 500 - 750 | Composition + VAT + segmental analysis + doctor read |
| Premium longevity clinic (Jumeirah, Palm Jumeirah) | 750 - 1,200 | Full report + consultation + comparison overlay |
| Quarterly package (4 scans) | 1,800 - 2,800 | Same operator, locked pricing, trended dashboard |
If you are running a serious 48-week protocol, the quarterly package math is almost always better than per-scan billing. Several sports-medicine clinics in Business Bay and Dubai Marina now offer this specifically because the body-composition tracking demand from GLP-1 and triple-agonist researchers has grown sharply through 2025 and 2026.
Supply continuity is the second pillar of a clean DEXA-tracked retatrutide protocol. REVIVE LAB UAE operates from Dubai with cold-chain courier coverage across all seven emirates. Standard delivery windows are below — if your order is confirmed before the Dubai cutoff, same-day delivery inside Dubai is the default, not an upgrade.
| Emirate / Region | Delivery Window | Cash on Delivery |
|---|---|---|
| Dubai (all areas) | Same-day (order before 2pm) or next-day | Yes |
| Abu Dhabi | Next-day (24h) | Yes |
| Sharjah | Same-day or next-day | Yes |
| Ajman | Next-day (24h) | Yes |
| Ras Al Khaimah (RAK) | 24-48h | Yes |
| Fujairah | 24-48h | Yes |
| Umm Al Quwain (UAQ) | 24-48h | Yes |
| Al Ain | Next-day (24h) | Yes |
Inside Dubai, our courier network covers Dubai Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, Downtown, Emirates Hills and Arabian Ranches with cold-chain insulated packaging and discreet anonymous boxing — no peptide branding visible from the outside. Cash on delivery is standard. Card and bank transfer are also available for researchers running larger 48-week protocol orders. This is the operational backbone of why REVIVE LAB UAE has become the default peptides Dubai supplier for serious body-composition work in the Emirates.
REVIVE LAB UAE is a UAE-based, UAE-stocked peptides supplier — your vials are not coming from a Hong Kong warehouse three weeks late. Every batch of retatrutide 5 mg and 10 mg is HPLC-tested for purity before release, then held under cold-chain conditions through dispatch. Same-day Dubai dispatch is the operational default, not a premium tier. Packaging is fully discreet and anonymous, so a Business Bay tower concierge or an Arabian Ranches villa neighbor sees only a plain courier box. Cash on delivery is supported across all seven emirates. If you are building a 48-week DEXA-tracked protocol, this is the supply chain you want behind it. Browse the full stock catalogue at REVIVE LAB UAE peptides Dubai.
Once you have two scans, you have a delta. Once you have four, you have a trajectory. Here is the rough rubric most researchers use when reviewing a retatrutide DEXA series:
If three consecutive quarters show fat loss under 60% of total weight loss, the dose is probably not the problem — the surrounding protocol is. Bump protein, add a second weekly resistance session, and rerun the next scan before changing the retatrutide titration.
REVIVE LAB UAE stocks retatrutide 5 mg and 10 mg vials with same-day Dubai dispatch and 24h delivery to Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, Umm Al Quwain and Al Ain. All shipments use insulated cold-chain packaging and discreet anonymous boxing. Cash on delivery is available across all emirates, making REVIVE the practical default for buying peptides UAE researchers actually trust for a 48-week protocol.
For research tracking, a baseline DEXA before week 0 and follow-ups every 12 weeks (quarterly) is the most informative cadence. This mirrors how Jastreboff 2023 NEJM reported body composition shifts at 24 and 48 weeks. Five scans across a full 48-week protocol gives you four quarterly deltas, which is the minimum resolution to separate fat loss from lean loss reliably.
Private DEXA body-composition scans in Dubai and Abu Dhabi typically range from AED 350 at a standard radiology center to AED 1,200 at premium longevity clinics in Jumeirah or Palm Jumeirah. Sports-medicine clinics in Dubai Marina, JBR, Business Bay and DIFC commonly bundle quarterly scans into a four-scan package between AED 1,800 and AED 2,800, which is the most cost-effective option for a 48-week retatrutide protocol.